BUSINESS

• Nichi-Iko Wins Patent Suit over Elplat
  November 1, 2016

• Shionogi Nets 12.2% Sales Rise on HIV Med Royalty Revenues
  November 1, 2016

• Daiichi Sankyo Earnings Lower on Yen Moves; Olmesartan Suffers 21.8% Slide
  November 1, 2016

• Forex Moves Drag Down Eisai’s Half-Year Sales despite Bullish Global Brands
  November 1, 2016

• Keytruda “Will Be Able to Contribute to 1st-Line Treatment” of NSCLC: MSD Official
  November 1, 2016

• EA Pharma Files Japan NDA for Rectal-Foam Ulcerative Colitis Drug
  October 31, 2016

• AZ to Commercialize Kyowa Kirin’s COPD Drug in Japan
  October 31, 2016

• Astellas to Acquire German Cancer Biotech Ganymed
  October 31, 2016

• Xtandi Re-Pricing Major Cause of Japan Sales Slump: Astellas President
  October 31, 2016

• Astellas Sees Sales Drop, but Profits Grow on Lower Costs
  October 31, 2016

• Takeda Ditches Flu Vaccine TAK-850 from Pipeline
  October 31, 2016

• Takeda’s Half-Year Sales Slip on LLP Transfer, but Profits Zoom
  October 31, 2016

• Kyowa Kirin Begins Global KRN23 PIII for Pediatric X-Linked Hypophosphatemia
  October 28, 2016

• Sumitomo Dainippon’s Half-Year Revenue Dips on Price Cut, Currency
  October 28, 2016

• Sumitomo Dainippon to Venture into Authorized Generic Arena
  October 28, 2016

• Public “IP Platforms” Necessary for Startups: IPSN President
  October 28, 2016

• Daiichi Sankyo Gets US Commercialization Rights on 2 Abuse-Deterrent Opioids
  October 27, 2016

• Patritumab Joins I-SPY 2 Breast Cancer Program in US: Daiichi Sankyo
  October 27, 2016

• Switching Over to Biologics Should Be Considered at Early Stage in Serious Cases of Psoriasis: Dermatologist
  October 27, 2016

• AZ Japan Sees Combo Holding Promise in Immuno-Oncology Race, Set to Triple Oncology Sales in 5 Years
  October 26, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 463
• 464
• 465
• 466
• 467
• 468
• 469
• 470
• 471
• …
• Next ›
• 最終 »